Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits

BACKGROUND: Myanmar has set national hepatitis C (HCV) targets to achieve 50% of people diagnosed and 50% treated by 2030. The WHO has additional targets of reducing incidence by 80% and mortality by 65% by 2030. We aimed to estimate the impact, cost, cost-effectiveness and net economic benefit of a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Lancet Reg Health West Pac
Main Authors: Scott, Nick, Win, Thin Mar, Tidhar, Tom, Htay, Hla, Draper, Bridget, Aung, Phyo Thu Zar, Xiao, Yinzong, Bowring, Anna, Kuschel, Christian, Shilton, Sonjelle, Kyi, Khin Pyone, Naing, Win, Aung, Khin Sanda, Hellard, Margaret
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2021
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8315611/
https://ncbi.nlm.nih.gov/pubmed/34327345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lanwpc.2021.100129
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares